Both parties are currently identifying investment opportunities in promising products and new scientific approaches, combined with the use of efficient investment strategies and flexible funding mechanisms.
Mõlemad osapooled püüavad praegu leida võimalusi paljulubavatesse tervishoiutoodetesse ja uutesse teaduslikesse vaatenurkadesse investeerimiseks, rakendades sealjuures tõhusaid investeerimisstrateegiad ja paindlikke rahastamismehhanisme.